Ceretype Neuromedicine

Alto Neuroscience

This biopharmaceutical company develops precision medicines for patients with neuropsychiatric conditions by using an artificial intelligence platform to analyse brain-based biomarkers.

Et Cere

This company develops image processing software to identify brain biotypes from neuroimaging data for clinicians and patients to personalise depression and anxiety treatments.

Hemispheric

This company develops artificial intelligence models and platforms for decoding non-invasive brain signals to assist clinicians and researchers with neurological and psychiatric diagnoses.

Brooklyn Health

This neuroscience technology company develops an artificial intelligence platform to provide objective mental health measurement for pharmaceutical companies conducting clinical trials.

NeuraLight

The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.

Exin Therapeutics

This company develops an artificial intelligence platform to discover and design neurotherapeutics targeting neural circuits for patients with neurological and neuropsychiatric disorders.

Neuronostics

The company develops an EEG-based digital biomarker platform to provide objective diagnostic and prognostic support for epilepsy to healthcare providers and pharmaceutical researchers.

BrainQuant

This company develops artificial intelligence software that analyses magnetic resonance imaging sequences to detect neurodegenerative diseases for medical institutions and clinical researchers.